Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Mar 13 2025

Full Issue

Research Roundup: The Latest Science, Discoveries, And Breakthroughs

Each week, KFF Health News compiles a selection of the latest health research and news.

FiercePharma: AstraZeneca Says Imfinzi Keeps Stomach Cancer From Coming Back

AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in early-stage stomach cancer met its main goal. When added to a chemotherapy combination called FLOT, Imfinzi significantly reduced the risk of disease recurrence, worsening or death in patients with resectable, early-stage gastric and gastroesophageal junction cancers who got the regimen before and after surgery, the company said Friday. (Liu, 3/7)

ScienceDaily: Targeted Alpha Therapy: Breakthrough In Treating Refractory Skin Cancer 

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha particles. (Chiba University, 3/12)

MedPage Today: Rapid, Substantial Psoriasis Improvement With Oral IL-23 Inhibitor 

Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an oral peptide targeting interleukin (IL)-23, a randomized study showed. The primary analysis showed that 65% of patients treated with icotrokinra had an investigator global assessment (IGA) score of 0/1 as compared with 8% of patients assigned to placebo. Half of the patients had 90% skin clearance by the Psoriasis Area and Severity Index (PASI 90) versus 4% of the placebo group. (Bankhead, 3/9)

CIDRAP: 5-Strain Meningitis Vaccine Shows Promise In Very Young Kids

The results of a phase 3 randomized clinical trial support the use of a vaccine that protects against five strains of meningitis in routine childhood immunization programs in countries with a high burden of meningococcal disease, an international team of researchers reported yesterday in The Lancet. (Dall, 3/12)

CIDRAP: Animal, Environmental Sources Cause Most US Foodborne Illness Outbreaks, CDC Reports 

Many US foodborne illness outbreaks are caused by contamination of food from an animal or environmental source before final preparation, with most viral outbreaks triggered by infected food workers, and foods left out for a prolonged period plus inadequate time and temperature control during cooking contribute to bacterial outbreaks, according to new data from Foodborne Disease Outbreak Surveillance System (FDOSS). The report was published today in Morbidity and Mortality Weekly Report. (Van Beusekom, 3/12)

CIDRAP: Cow-Derived Avian Flu Can Infect Pigs But Doesn't Spread Among Them, Preprint Suggests 

Pigs are moderately susceptible to infection with a bovine-derived H5N1 avian influenza virus but don't spread it to other pigs, a non–peer-reviewed study published on the preprint server bioRxiv suggests. (Van Beusekom, 3/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF